[1]	Dias DA , Urban S , Roessner U . A historical overview of natural products in drug discovery. Metabolites. 2012; 2 (2): 303- 336. CrossRef Google scholar

[2]	Panigrahi GK , Sahoo A , Satapathy KB . Insights to plant immunity: defense signaling to epigenetics. Physiol Mol Plant Pathol. 2021; 113: 101568. CrossRef Google scholar

[3]	Jones AW . Early drug discovery and the rise of pharmaceutical chemistry. Drug Test Anal. 2011; 3 (6): 337- 344. Jun. CrossRef Google scholar

[4]	Singh N , Vayer P , Tanwar S , Poyet JL , Tsaioun K , Villoutreix BO . Drug discovery and development: introduction to the general public and patient groups. Front Drug Disco. 2023; 3: 1201419. CrossRef Google scholar

[5]	Singh S , Kumar R , Payra S , Singh SK . Artificial intelligence and machine learning in pharmacological research: bridging the gap between data and drug discovery. Cureus. 2023; 15 (8): e44359. Aug 30. CrossRef Google scholar

[6]	Hopkins AL , Groom CR . The druggable genome. Nat Rev Drug Discov. 2002; 1 (9): 727- 730. CrossRef Google scholar

[7]	Xu H , Xu H , Lin M , et al. Learning the drug target-likeness of a protein. Proteomics. 2007; 7 (23): 4255- 4263. CrossRef Google scholar

[8]	Patro I , Sahoo A , Nayak BR , Das R , Majumder S , Panigrahi GK . Nonsense-mediated mRNA decay: mechanistic insights and physiological significance. Mol Biotechnol. 2023: 1- 15. CrossRef Google scholar

[9]	Sakharkar MK , Rajamanickam K , Babu CS , Madan J , Chandra R , Yang J . Preclinical: Drug Target Identification and Validation in Human. 2019. CrossRef Google scholar

[10]	Emmerich CH , Gamboa LM , Hofmann MC , et al. Improving target assessment in biomedical research: the GOT-IT recommendations. Nat Rev Drug Discov. 2021; 20 (1): 64- 81. CrossRef Google scholar

[11]	Ikeda K , Maezawa Y , Yonezawa T , et al. DLiP-PPI library: an integrated chemical database of small-to-medium-sized molecules targeting protein-protein interactions. Front Chem. 2023; 10: 1090643. CrossRef Google scholar

[12]	Chaudhari R , Fong LW , Tan Z , Huang B , Zhang S . An up-to-date overview of computational polypharmacology in modern drug discovery. Expet Opin Drug Discov. 2020; 15 (9): 1025- 1044. CrossRef Google scholar

[13]	Kabir A , Muth A . Polypharmacology: the science of multi-targeting molecules. Pharmacol Res. 2022; 176: 106055. Feb. CrossRef Google scholar

[14]	Hassan Baig M , Ahmad K , Roy S , et al. Computer aided drug design: success and limitations. Curr Pharmaceut Des. 2016; 22 (5): 572- 581. CrossRef Google scholar

[15]	Gurung AB , Ali MA , Lee J , Farah MA , Al-Anazi KM . An updated review of computer-aided drug design and its application to COVID-19. BioMed Res Int. 2021: 2021. CrossRef Google scholar

[16]	Giordano D , Biancaniello C , Argenio MA , Facchiano A . Drug design by pharmacophore and virtual screening approach. Pharmaceuticals. 2022; 15 (5): 646. CrossRef Google scholar

[17]	Alhaji Isa M , Singh Majumdar R . Computer-aided drug design based on comparative modeling, molecular docking and molecular dynamic simulation of Polyphosphate kinase (PPK) from Mycobacterium tuberculosis. J Protein Proteonomics. 2019; 10: 55- 68. CrossRef Google scholar

[18]	Katsila T , Spyroulias GA , Patrinos GP , Matsoukas MT . Computational approaches in target identification and drug discovery. Comput Struct Biotechnol J. 2016; 14: 177- 184. CrossRef Google scholar

[19]	Blanco-Gonzalez A , Cabezon A , Seco-Gonzalez A , et al. The role of ai in drug discovery: challenges, opportunities, and strategies. Pharmaceuticals. 2023; 16 (6): 891. CrossRef Google scholar

[20]	Kiriiri GK , Njogu PM , Mwangi AN . Exploring different approaches to improve the success of drug discovery and development projects: a review. Futur J Pharm Sci. 2020; 6. CrossRef Google scholar

[21]	Karmakar P , Trivedi A , Gaitonde V . Introductory Chapter: The Modern-Day Drug Discovery. Drug Discovery and Development-New Advances; 2020. CrossRef Google scholar

[22]	Leelananda SP , Lindert S . Computational methods in drug discovery. Beilstein J Org Chem. 2016; 12 (1): 2694- 2718. CrossRef Google scholar

[23]	Maia EHB , Assis LC , De Oliveira TA , Da Silva AM , Taranto AG . Structure-based virtual screening: from classical to artificial intelligence. Front Chem. 2020; 8: 343. CrossRef Google scholar

[24]	Damm-Ganamet KL , Arora N , Becart S , et al. Accelerating lead identification by high Throughput virtual screening: prospective case studies from the pharmaceutical industry. J Chem Inf Model. 2019; 59 (5): 2046- 2062. CrossRef Google scholar

[25]	Lavecchia A , Di Giovanni C . Virtual screening strategies in drug discovery: a critical review. Curr Med Chem. 2013; 20 (23): 2839- 2860. CrossRef Google scholar

[26]	Liu SH , Xiao Z , Mishra SK , et al. Identification of small-molecule inhibitors of fibroblast growth factor 23 signaling via in silico hot spot prediction and molecular docking to α-Klotho. J Chem Inf Model. 2022; 62 (15): 3627- 3637. CrossRef Google scholar

[27]	Liu X , Yi W , Xi B , Dai Q . Identification of drug-disease associations using a random walk with restart method and supervised learning. Comput Math Methods Med. 2022: 1- 10, 7035634. CrossRef Google scholar

[28]	Ibrahim MA , Abdeljawaad KA , Abdelrahman AH , et al. Exploring natural product activity and species source candidates for hunting ABCB1 transporter inhibitors: an in silico drug discovery study. Molecules. 2022; 27 (10): 3104. CrossRef Google scholar

[29]	Zhang Q , Han J , Zhu Y , et al. Discovery of novel and potent InhA direct inhibitors by ensemble docking-based virtual screening and biological assays. J Comput Aided Mol Des. 2023; 37 (12): 695- 706. CrossRef Google scholar

[30]	Zhang Y , Li S , Xing M , Yuan Q , He H , Sun S . Universal approach to de novo drug design for target proteins using deep reinforcement learning. ACS Omega. 2023; 8 (6): 5464- 5474. CrossRef Google scholar

[31]	Anand R . Identification of potential antituberculosis drugs through docking and virtual screening. Interdiscipl Sci Comput Life Sci. 2018; 10: 419- 429. CrossRef Google scholar

[32]	Bagherian M , Sabeti E , Wang K , Sartor MA , Nikolovska-Coleska Z , Najarian K . Machine learning approaches and databases for prediction of drug-target interaction: a survey paper. Briefings Bioinf. 2021; 22 (1): 247- 269. CrossRef Google scholar

[33]

Burley SK , Bhikadiya C , Bi C , et al. RCSB Protein Data Bank: powerful new tools for exploring 3D structures of biological macromolecules for basic and applied research and education in fundamental biology, biomedicine, biotechnology, bioengineering and energy sciences. Nucleic Acids Res. 2021; 49 (D1): D437- D451. CrossRef Google scholar

[34]	Jadaun A , Subbarao N , Dixit A . Allosteric inhibition of topoisomerase I by pinostrobin: molecular docking, spectroscopic and topoisomerase I activity studies. J Photochem Photobiol B Biol. 2017; 167: 299- 308. CrossRef Google scholar

[35]	Sethi A , Joshi K , Sasikala K , Alvala M . Molecular docking in modern drug discovery: principles and recent applications. Drug disco develo new adv. 2019; 2: 1- 21. CrossRef Google scholar

[36]	Halder D , Das S , Jeyaprakash RS . Identification of natural product as selective PI3Kα inhibitor against NSCLC: multi-ligand pharmacophore modeling, molecular docking, ADME, DFT, and MD simulations. Mol Divers. 2023. Sep 15. CrossRef Google scholar

[37]	Shah Manan , Patel Maanit , Shah Monit , Patel Monali , Prajapati Mitul . Computational transformation in drug discovery: a comprehensive study on molecular docking and quantitative structure activity relationship (QSAR). Intelligent Pharmacy. 2024. CrossRef Google scholar

[38]	Matter H , Sotriffer C . Applications and success stories in virtual screening. In: Sotriffer C, ed. Virtual Screening: Principles, Challenges, and Practical Guidelines. Weinheim, Germany: Wiley-VCH Verlag GmbH & Co. KGaA; 2011: 319- 358. CrossRef Google scholar

[39]	Pina AS , Hussain A , Roque ACA . An historical overview of drug discovery. LigandMacromolecular Interactions Drug Disco: Metho Proto. 2010: 3- 12. CrossRef Google scholar

[40]	Doytchinova I . Drug design—past, present, future. Molecules. 2022; 27 (5): 1496. CrossRef Google scholar

[41]	Mohs RC , Greig NH . Drug discovery and development: role of basic biological research. Alzheimers Dement. 2017; 3 (4): 651- 657. Nov 11. CrossRef Google scholar

[42]	Behera A , Panigrahi GK , Sahoo SK . Nonsense-Mediated mRNA decay in human health and diseases: current understanding, regulatory mechanisms and future perspectives. Mol Biotechnol. 2024. CrossRef Google scholar

[43]	Qin D . Next-generation sequencing and its clinical application. Cancer Biol Med. 2019; 16 (1): 4- 10. Feb. CrossRef Google scholar

[44]	Zhao BW , Su XR , Hu PW , Huang YA , You ZH , Hu L . iGRLDTI: an improved graph representation learning method for predicting drug-target interactions over heterogeneous biological information network. Bioinformatics. 2023; 39 (8): btad451. CrossRef Google scholar

[45]	Nisha CM , Kumar A , Nair P , et al. Molecular docking and in silico ADMET study reveals acylguanidine 7a as a potential inhibitor of β-secretase. Adv bioinform. 2016: 2016. CrossRef Google scholar

[46]	Dara S , Dhamercherla S , Jadav SS , Babu CM , Ahsan MJ . Machine learning in drug discovery: a review. Artif Intell Rev. 2022; 55 (3): 1947- 1999. CrossRef Google scholar

[47]	Carpenter KA , Huang X . Machine learning-based virtual screening and its applications to Alzheimer's drug discovery: a review. Curr Pharmaceut Des. 2018; 24 (28): 3347- 3358. CrossRef Google scholar

[48]	Oliveira TAD , Silva MPD , Maia EHB , Silva AMD , Taranto AG . Virtual screening algorithms in drug discovery: a review focused on machine and deep learning methods. Drugs Drug Candida. 2023; 2 (2): 311- 334. CrossRef Google scholar

[49]	Gupta R , Srivastava D , Sahu M , Tiwari S , Ambasta RK , Kumar P . Artificial intelligence to deep learning: machine intelligence approach for drug discovery. Mol Divers. 2021; 25: 1315- 1360. CrossRef Google scholar

[50]	Niazi SK , Mariam Z . Recent advances in machine-learning-based chemoinformatics: a comprehensive review. Int J Mol Sci. 2023; 24 (14): 11488. Jul 15. CrossRef Google scholar

[51]	Batool M , Ahmad B , Choi S . A structure-based drug discovery paradigm. Int J Mol Sci. 2019; 20 (11): 2783. CrossRef Google scholar

[52]	Gibbs RA . The human genome project changed everything. Nat Rev Genet. 2020; 21 (10): 575- 576. CrossRef Google scholar

[53]	Somda D , Kpordze SW , Jerpkorir M , et al. The Role of Bioinformatics in Drug Discovery: A Comprehensive Overview. 2023. CrossRef Google scholar

[54]	Wingert BM , Camacho CJ . Improving small molecule virtual screening strategies for the next generation of therapeutics. Curr Opin Chem Biol. 2018; 44: 87- 92. Jun. CrossRef Google scholar

[55]	Singh SP , Panigrahi GK , Sahoo A . Optimizing nanoparticles use for growth promotion in zebrafish: insights on concentration-dependent effects. Nanotechnol Environ Eng. 2024. CrossRef Google scholar

[56]	Paananen Jussi , Fortino Vittorio . An omics perspective on drug target discovery platforms. Briefings Bioinf. 2020; 21 (6). November. CrossRef Google scholar

[57]	Xia X . Bioinformatics and drug discovery. Curr Top Med Chem. 2017; 17 (15): 1709- 1726. CrossRef Google scholar

[58]	Wooller SK , Benstead-Hume G , Chen X , Ali Y , Pearl FM . Bioinformatics in translational drug discovery. Biosci Rep. 2017; 37 (4): BSR20160180. CrossRef Google scholar

[59]	Aggarwal S , Karmakar A , Krishnakumar S , et al. Advances in drug discovery based on genomics, proteomics and bioinformatics in malaria. Curr Top Med Chem. 2023; 23 (7): 551- 578. CrossRef Google scholar

[60]	Russell C , Rahman A , Mohammed AR . Application of genomics, proteomics and metabolomics in drug discovery, development and clinic. Ther Deliv. 2013; 4 (3): 395- 413. CrossRef Google scholar

[61]	de Oliveira Viana J , Scotti MT , Scotti L . Molecular docking studies in multitarget antitubercular drug discovery. Multi-Target Drug Design Using Chem-Bioinformatic Approaches. 2019: 107- 154. CrossRef Google scholar

[62]	Zhang Y , Luo M , Wu P , Wu S , Lee TY , Bai C . Application of computational biology and artificial intelligence in drug design. Int J Mol Sci. 2022; 23 (21): 13568. CrossRef Google scholar

[63]	Li H , Yang Y , Hong W , Huang M , Wu M , Zhao X . Applications of genome editing technology in the targeted therapy of human diseases: mechanisms, advances and prospects. Signal Transduct Targeted Ther. 2020; 5 (1): 1. CrossRef Google scholar

[64]	Li K , Du Y , Li L , Wei DQ . Bioinformatics approaches for anti-cancer drug discovery. Curr Drug Targets. 2020; 21 (1): 3- 17. CrossRef Google scholar

[65]	Koromina M , Pandi MT , Patrinos GP . Rethinking drug repositioning and development with artificial intelligence, machine learning, and omics. OMICS, Nov. 2019; 23 (11): 539- 548. CrossRef Google scholar

[66]	Chakraborty C , Teoh SL , Das S . The smart programmable CRISPR technology: a next generation genome editing tool for investigators. Curr Drug Targets. 2017; 18 (14): 1653- 1663. CrossRef Google scholar

[67]	Zhang C , Quan R , Wang J . Development and application of CRISPR/Cas9 technologies in genomic editing. Hum Mol Genet. 2018; 27 (R2): R79- R88. Aug 1. CrossRef Google scholar

[68]	Chanchal DK , Chaudhary JS , Kumar P , Agnihotri N , Porwal P . CRISPR-based therapies: revolutionizing drug development and precision medicine. Curr Gene Ther. 2024; 24 (3): 193- 207. CrossRef Google scholar

[69]	Liu W , Li L , Jiang J , Wu M , Lin P . Applications and challenges of CRISPR-Cas gene-editing to disease treatment in clinics. Precision clini med. 2021; 4 (3): 179- 191. CrossRef Google scholar

[70]	Fellmann C , Gowen BG , Lin PC , Doudna JA , Corn JE . Cornerstones of CRISPR-Cas in drug discovery and therapy. Nat Rev Drug Discov. 2017; 16 (2): 89- 100. CrossRef Google scholar

[71]	Chan YT , Lu Y , Wu J , et al. CRISPR-Cas9 library screening approach for anti-cancer drug discovery: overview and perspectives. Theranostics. 2022; 12 (7): 3329. CrossRef Google scholar

[72]	Zou J , Zheng MW , Li G , Su ZG . Advanced systems biology methods in drug discovery and translational biomedicine. BioMed Res Int. 2013: 2013. CrossRef Google scholar

[73]	Yue R , Dutta A . Computational systems biology in disease modeling and control, review and perspectives. npj Syst Biol Appl. 2022. CrossRef Google scholar

[74]	Ebrahimi A , Roshani F . Systems biology approaches to identify driver genes and drug combinations for treating COVID-19. Sci Rep. 2024; 14 (1): 2257. CrossRef Google scholar

[75]	Leung EL , Cao ZW , Jiang ZH , Zhou H , Liu L . Network-based drug discovery by integrating systems biology and computational technologies. Briefings Bioinf. 2013; 14 (4): 491- 505. CrossRef Google scholar

[76]	Chua HN , Roth FP . Discovering the targets of drugs via computational systems biology. J Biol Chem. 2011; 286 (27): 23653- 23658. Jul 8. CrossRef Google scholar

[77]	Malandraki-Miller S , Riley PR . Use of artificial intelligence to enhance phenotypic drug discovery. Drug Discov Today. 2021; 26 (4): 887- 901. Apr. CrossRef Google scholar

[78]	Chan HS , Shan H , Dahoun T , Vogel H , Yuan S . Advancing drug discovery via artificial intelligence. Trends Pharmacol Sci. 2019; 40 (8): 592- 604. CrossRef Google scholar

[79]	Deng L , Zhong W , Zhao L , et al. Artificial intelligence-based application to explore inhibitors of neurodegenerative diseases. Front Neurorob. 2020; 14: 617327. CrossRef Google scholar

[80]	Tripathi MK , Nath A , Singh TP , Ethayathulla AS , Kaur P . Evolving scenario of big data and Artificial Intelligence (AI) in drug discovery. Mol Divers. 2021; 25: 1439- 1460. CrossRef Google scholar

[81]	Mak KK , Pichika MR . Artificial intelligence in drug development: present status and future prospects. Drug Discov Today. 2019; 24 (3): 773- 780. CrossRef Google scholar

[82]	Cruz JA , Wishart DS . Applications of machine learning in cancer prediction and prognosis. Cancer Inf. 2006; 2: 117693510600200030. CrossRef Google scholar

[83]	Paul D , Sanap G , Shenoy S , Kalyane D , Kalia K , Tekade RK . Artificial intelligence in drug discovery and development. Drug Discov Today. 2021; 26 (1): 80- 93. CrossRef Google scholar

[84]	Selvaraj C , Chandra I , Singh SK . Artificial intelligence and machine learning approaches for drug design: challenges and opportunities for the pharmaceutical industries. Mol Divers. 2021: 1- 21. CrossRef Google scholar

[85]	Kumar M , Nguyen TN , Kaur J , et al. Opportunities and challenges in application of artificial intelligence in pharmacology. Pharmacol Rep. 2023; 75 (1): 3- 18. CrossRef Google scholar

[86]	Han R , Yoon H , Kim G , Lee H , Lee Y . Revolutionizing medicinal chemistry: the application of artificial intelligence (AI) in early drug discovery. Pharmaceuticals. 2023; 16 (9): 1259. CrossRef Google scholar

[87]	Álvarez-Machancoses Ó , Fernández-Martínez JL . Using artificial intelligence methods to speed up drug discovery. Expet Opin Drug Discov. 2019; 14 (8): 769- 777. CrossRef Google scholar

[88]	Bess A , Berglind F , Mukhopadhyay S , et al. Artificial intelligence for the discovery of novel antimicrobial agents for emerging infectious diseases. Drug Discov Today. 2022; 27 (4): 1099- 1107. CrossRef Google scholar

[89]	Visan AI , Negut I . Integrating artificial intelligence for drug discovery in the context of revolutionizing drug delivery. Life. 2024; 14 (2): 233. Feb 7. CrossRef Google scholar

[90]	Jeon J , Nim S , Teyra J , et al. A systematic approach to identify novel cancer drug targets using machine learning, inhibitor design and high-throughput screening. Genome Med. 2014; 6: 1- 18. CrossRef Google scholar

[91]	Vamathevan J , Clark D , Czodrowski P , et al. Applications of machine learning in drug discovery and development. Nat Rev Drug Discov. 2019; 18 (6): 463- 477. CrossRef Google scholar

[92]	Lee I , Keum J , Nam H . DeepConv-DTI: prediction of drug-target interactions via deep learning with convolution on protein sequences. PLoS Comput Biol. 2019; 15 (6): e1007129. Jun 14. CrossRef Google scholar

[93]	Bender A , Cortés-Ciriano I . Artificial intelligence in drug discovery: what is realistic, what are illusions? Part 1: ways to make an impact, and why we are not there yet. Drug Discov Today. 2021; 26 (2): 511- 524. CrossRef Google scholar

[94]	Sliwoski G , Kothiwale S , Meiler J , Lowe EW . Computational methods in drug discovery. Pharmacol Rev. 2014; 66 (1): 334- 395. CrossRef Google scholar

[95]	Khan O , Badhiwala JH , Grasso G , Fehlings MG . Use of machine learning and artificial intelligence to drive personalized medicine approaches for spine care. World neurosurgery. 2020; 140: 512- 518. CrossRef Google scholar

[96]	Bravo Serrano À , Piñero González J , Queralt Rosinach N , Rautschka M , Furlong LI . Extraction of relations between genes and diseases from text and large-scale data analysis: implications for translational research. BMC Bioinf. 2015; 16 (1): 55, 2015 Feb 21. CrossRef Google scholar

[97]	Song M , Kim M , Kang K , Kim YH , Jeon S . Application of public knowledge discovery tool (pkde4j) to represent biomedical scientific knowledge. Front Res Metr Anal. 2018; 3: 7. CrossRef Google scholar

[98]	Alam T , Schmeier S . Deep learning in biomedical text mining: contributions and challenges. In: Multiple Perspectives on Artificial Intelligence in Healthcare: Opportunities and Challenges. Cham: Springer International Publishing; 2021: 169- 184. CrossRef Google scholar

[99]	Sebastiano MR , Ermondi G , Hadano S , Caron G . AI-based protein structure databases have the potential to accelerate rare diseases research: AlphaFoldDB and the case of IAHSP/Alsin. Drug Discov Today. 2022; 27 (6): 1652- 1660. CrossRef Google scholar

[100]

Jumper J , Evans R , Pritzel A , et al. Highly accurate protein structure prediction with AlphaFold. Nature. 2021; 596 (7873): 583- 589. CrossRef Google scholar

[101]

Bhhatarai B , Walters WP , Hop CE , Lanza G , Ekins S . Opportunities and challenges using artificial intelligence in ADME/Tox. Nat Mater. 2019; 18 (5): 418- 422. CrossRef Google scholar

[102]

Panigrahi GK , Sahoo A , Satapathy KB . Differential expression of selected Arabidopsis resistant genes under abiotic stress conditions. Plant Sci Today. 2021; 8 (4): 859- 864. CrossRef Google scholar

[103]

Wang DD , Zhu M , Yan H . Computationally predicting binding affinity in proteinligand complexes: free energy-based simulations and machine learning-based scoring functions. Briefings Bioinf. 2021; 22 (3): bbaa107. CrossRef Google scholar

[104]

Born J , Manica M . Trends in deep learning for property-driven drug design. Curr Med Chem. 2021; 28 (38): 7862- 7886. CrossRef Google scholar

[105]

Panigrahi GK , Satapathy KB . Arabidopsis DCP5, a Decapping Complex Protein Interacts with Ubiquitin-5 in the Processing Bodies. 2020.

[106]

Sahoo A , Satapathy KB . Differential expression of Arabidopsis EJC core proteins under short-day and long-day growth conditions. Plant Sci Today. 2021; 8 (4): 815- 819. CrossRef Google scholar

[107]

Panigrahi GK , Satapathy KB . Formation of Arabidopsis Poly (A)-Specific Ribonuclease associated processing bodies in response to pathogenic infection. Plant Archives. 2020; 20 (2): 4907- 4912.

[108]

Panigrahi GK , Satapathy KB . Sacrificed surveillance process favours plant defense: a review. Plant Archives. 2020; 20 (2).

[109]

McGibbon M , Money-Kyrle S , Blay V , Houston DR . SCORCH: improving structure-based virtual screening with machine learning classifiers, data augmentation, and uncertainty estimation. J Adv Res. 2023; 46: 135- 147. CrossRef Google scholar

[110]

Singh S , Gupta H , Sharma P , Sahi S . Advances in Artificial Intelligence (AI)-assisted approaches in drug screening. Artific Intellig Chem. 2024; 2 (1): 100039. CrossRef Google scholar

[111]

Hughes JP , Rees S , Kalindjian SB , Philpott KL . Principles of early drug discovery. Br J Pharmacol. 2011; 162 (6): 1239- 1249. Mar. CrossRef Google scholar

[112]

Berrhail F , Belhadef H , Haddad M . Deep Convolutional Neural Network to improve the performances of screening process in LBVS. Expert Syst Appl. 2022; 203: 117287. CrossRef Google scholar

[113]

Bustamam A , Hamzah H , Husna NA , et al. Artificial intelligence paradigm for ligand-based virtual screening on the drug discovery of type 2 diabetes mellitus. J Big Data. 2021; 8 (1): 74. CrossRef Google scholar

[114]

Kim S , Cho KH . PyQSAR: a fast QSAR modeling platform using machine learning and jupyter notebook. Bull Kor Chem Soc. 2019; 40 (1): 39- 44. CrossRef Google scholar

[115]

Mu G , Liu H , Wen Y , Luan F . Quantitative structure-property relationship study for the prediction of characteristic infrared absorption of carbonyl group of commonly used carbonyl compounds. Vib Spectrosc. 2011; 55 (1): 49- 57. CrossRef Google scholar

[116]

Soares TA , Nunes-Alves A , Mazzolari A , Ruggiu F , Wei GW , Merz K . The (Re)-Evolution of Quantitative Structure-Activity Relationship (QSAR) studies propelled by the surge of machine learning methods. J Chem Inf Model. 2022; 62 (22): 5317- 5320. CrossRef Google scholar

[117]

Prabha T , Selvinthanuja C , Hemalatha S , Sengottuvelu S , Senthil J . Machine learning algorithm used to build a QSAR model for pyrazoline scaffold as antitubercular agent. J Med Pharm Allied Sci. 2021; 10: 4024- 4030. CrossRef Google scholar

[118]

Guan L , Yang H , Cai Y , et al. ADMET-score -a comprehensive scoring function for evaluation of chemical drug-likeness. MedChemComm. 2018; 10 (1): 148- 157. CrossRef Google scholar

[119]

Yang H , Sun L , Li W , Liu G , Tang Y . In silico prediction of chemical toxicity for drug design using machine learning methods and structural alerts. Front Chem. 2018; 6: 30. CrossRef Google scholar

[120]

Sahu A , Mishra J , Kushwaha N . Artificial intelligence (AI) in drugs and pharmaceuticals. Comb Chem High Throughput Screen. 2022; 25 (11): 1818- 1837. CrossRef Google scholar

[121]

Gu Y , Wang Y , Zhu K , Li W , Liu G , Tang Y . DBPP-Predictor: a novel strategy for prediction of chemical drug-likeness based on property profiles. J Cheminf. 2024; 16 (1): 4. CrossRef Google scholar

[122]

Kashyap K , Siddiqi MI . Recent trends in artificial intelligence-driven identification and development of anti-neurodegenerative therapeutic agents. Mol Divers. 2021; 25 (3): 1517- 1539. Aug. CrossRef Google scholar

[123]

Chopra H , Shin DK , Munjal K , Dhama K , Emran TB . Revolutionizing clinical trials: the role of AI in accelerating medical breakthroughs. Int J Surg. 2023; 109 (12): 4211- 4220. CrossRef Google scholar

[124]

Panigrahi GK , Satapathy KB . Pseudomonas syringae pv. syringae infection orchestrates the fate of the arabidopsis J domain containing cochaperone and decapping protein factor 5. Physiol Mol Plant Pathol. 2021; 113: 1- 9, 101598. CrossRef Google scholar

[125]

Sahoo A , Satapathy KB , Panigrahi GK . Ectopic expression of disease resistance protein promotes resistance against pathogen infection and drought stress in Arabidopsis. Physiol Mol Plant Pathol. 2023; 124: 1- 7, 101949. CrossRef Google scholar

[126]

Moret M , Pachon Angona I , Cotos L , et al. Leveraging molecular structure and bioactivity with chemical language models for de novo drug design. Nat Commun. 2023; 14 (1): 114. CrossRef Google scholar

[127]

Jung HW , Panigrahi GK , Jung G-Y , et al. PAMP-triggered immunity involves proteolytic degradation of core nonsense-mediated mRNA decay factors during early defense response. Plant Cell. 2020; 32 (4): 1081- 1101. CrossRef Google scholar

[128]

Sahoo A , Satapathy KB , Panigrahi GK . Security check: plant immunity under temperature surveillance. J Plant Biochem Biotechnol. 2023: 1- 4. CrossRef Google scholar

[129]

Panigrahi GK , Sahoo A , Satapathy KB . The processing body component varicose plays a multiplayer role towards stress management in Arabidopsis. Plant Physiol Rep. 2024: 1- 10. CrossRef Google scholar

[130]

Das R , Panigrahi GK . Messenger RNA surveillance: current understanding, regulatory mechanisms and future implications. Mol Biotechnol. 2024: 1- 18. CrossRef Google scholar

[131]

Tong X , Liu X , Tan X , et al. Generative models for de novo drug design. J Med Chem. 2021; 64 (19): 14011- 14027. CrossRef Google scholar

[132]

Mouchlis VD , Afantitis A , Serra A , et al. Advances in de novo drug design: from conventional to machine learning methods. Int J Mol Sci. 2021; 22 (4): 1676. CrossRef Google scholar

[133]

Martinelli DD . Generative machine learning for de novo drug discovery: A systematic review. Comput Biol Med. 2022; 145: 105403. CrossRef Google scholar

[134]

Li B , Tan K , Lao AR , Wang H , Zheng H , Zhang L . A comprehensive review of artificial intelligence for pharmacology research. Front Genet. 2024; 15: 1450529. CrossRef Google scholar

[135]

Meli R , Morris GM , Biggin PC . Scoring functions for protein-ligand binding affinity prediction using structure-based deep learning: a review. Front bioinform. 2022; 2: 885983. CrossRef Google scholar

[136]

Guan L , Yang H , Cai Y , et al. ADMET-score-a comprehensive scoring function for evaluation of chemical drug-likeness. Medchemcomm. 2019; 10 (1): 148- 157. CrossRef Google scholar

[137]

Guo S , Zhang D , Wang H , et al. Computational and systematic analysis of multiomics data for drug discovery and development. Front Med. 2023; 10: 1146896. CrossRef Google scholar

[138]

Zhong HA . ADMET properties: overview and current topics. In: Grover A, ed. Drug Design: Principles and Applications. Singapore: Springer; 2017. CrossRef Google scholar

[139]

Lv Q , Zhou F , Liu X , Zhi L . Artificial intelligence in small molecule drug discovery from 2018 to 2023: does it really work? Bioorg Chem. 2023: 106894. CrossRef Google scholar

[140]

Panigrahi GK , Sahoo SK , Sahoo A , et al. Bioactive molecules from plants: a prospective approach to combat SARS-CoV-2. Adv Tradit Med. 2023; 23 (3): 617- 630. CrossRef Google scholar

[141]

Pareek V , Tuteja L , Sharma L , Kumar S , Verma N . Revolutionizing drug design with artificial intelligence: a comprehensive review of techniques, applications, and case studies. J Pharmaceut Res. 2023; 22 (3): 104. CrossRef Google scholar

[142]

Pereira T , Abbasi M , Ribeiro B , Arrais JP . Diversity oriented deep reinforcement learning for targeted molecule generation. J Cheminf. 2021; 13 (1): 21. CrossRef Google scholar

[143]

Wang C , Hu G , Wang K , Brylinski M , Xie L , Kurgan L . PDID: database of molecular-level putative protein-drug interactions in the structural human proteome. Bioinformatics. 2016; 32 (4): 579- 586. CrossRef Google scholar

[144]

Yang F , Zhang Q , Ji X , et al. Machine learning applications in drug repurposing. Interdiscipl Sci Comput Life Sci. 2022; 14 (1): 15- 21. CrossRef Google scholar

[145]

Anokian E , Bernett J , Freeman A , et al. Machine Learning and Artificial Intelligence in Drug Repurposing-Challenges and Perspectives. DrugRxiv; 2024. CrossRef Google scholar

[146]

Fang Y , Pan X , Shen HB . De novo drug design by iterative multiobjective deep reinforcement learning with graph-based molecular quality assessment. Bioinformatics. 2023; 39 (4): btad157. CrossRef Google scholar

[147]

Juhn Y , Liu H . Artificial intelligence approaches using natural language processing to advance EHR-based clinical research. J Allergy Clin Immunol. 2020; 145 (2): 463- 469. CrossRef Google scholar

[148]

Askin S , Burkhalter D , Calado G , El Dakrouni S . Artificial intelligence applied to clinical trials: opportunities and challenges. Health Technol. 2023; 13 (2): 203- 213. CrossRef Google scholar